Solardis Health Ventures

Solardis Health Ventures is a healthcare-focused venture firm investing in early-stage companies across digital health, medical devices, and life sciences tools. Public detail on the firm’s exact stage focus and check size is thin from the inputs provided, but the positioning suggests seed and Series A activity with checks plausibly in the range of five hundred thousand to three million dollars as a co-lead or significant participant. The natural fit is a healthcare company with credible clinical or commercial validation, a focused team, and a clear path to either reimbursement, regulatory clearance, or enterprise traction depending on the model. AI-native founders building clinical decision support, diagnostics software, workflow automation, or specialty care platforms could plausibly engage, particularly if there is meaningful clinical or operational evidence behind the product. Pure consumer wellness, generalist SaaS without a healthcare wedge, and biopharma therapeutics are unlikely to match the firm’s narrower healthcare scope. Founders should expect sector-fluent diligence with clinical and commercial review, and a partnership orientation rather than a fast-follower investor profile. The best entry path is a warm introduction from a portfolio CEO, a healthcare banker, or a clinical advisor with relationships into the firm. Direct outreach to partners via LinkedIn or the firm’s website is acceptable for cold contact, paired with a sharp executive summary, current pipeline data, and a specific ask on round size and timing. This is a focused healthcare investor, so non-healthcare pitches will not advance.